Yannick van Sleen

Yannick van Sleen is an academic researcher with expertise in Immunology, Microbiology, Rheumatology, and Aging. His work focuses on inflammatory diseases, particularly Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR). Key research areas include fibroblast subtypes, macrophage biology, and age-related immune changes.

His recent publications highlight trends in vascular inflammation, biomarker discovery, and immune cell dynamics. Contributions to clinical research and diagnostics are evident through studies on fibroblast activation protein alpha and clonal hematopoiesis in GCA.

Van Sleen actively engages in public science communication, contributing to media discussions on vaccine efficacy in GCA patients and diagnostic advancements. His work aligns with UN Sustainable Development Goals (SDGs) related to health and well-being.